GlassScriptPhysician profile
Joseph B Greene
NPI 1649471756
$2,630.64
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,007 · 2020: $359 · 2021: $732 · 2022: $533.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $540.85 | 2019-2022 | |
| Abbvie INC. | $434.85 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $334.22 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $303.03 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $302.56 | 2019-2020 | |
| Allergan, INC. | $263.67 | 2019-2020 | |
| Shire North American Group INC | $121.49 | 2019 | |
| Supernus Pharmaceuticals, INC. | $102.53 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $69.68 | 2019-2020 | |
| Lundbeck LLC | $46.14 | 2019 | |
| Tris Pharma INC | $39.61 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $22.68 | 2022 | |
| Arbor Pharmaceuticals, INC. | $18.12 | 2019 | |
| Neurocrine Biosciences, INC. | $17.24 | 2019 | |
| Bausch Health US, LLC | $13.97 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.